Jeanne Kehren

Jeanne Kehren graduated from the Maisons-Alfort Veterinary School and holds a master in Virology from Pasteur Institute and a PhD in Immunology from the Paris 7 University. Jeanne started her career at Novartis, where she worked in different R&D roles and drove the integration of innovative technologies in drug development. She also fostered the integration of large-scale data in pre-clinical and clinical investigations and developed biomarker and stratification approaches across different disease areas. She joined Sanofi in 2009 as Project Director and held successive positions in Product Development across different therapeutic areas, bringing together Commercial, R&D and Industrial Affairs teams on some major development projects. After joining the Global Strategic Development group in charge of products and Franchise investment strategies, she took the lead of the Early Assets group for Diabetes & Cardiovascular and Primary Care working on the reshaping of the portfolio and the development of new businesses. Jeanne joined Bayer in 2019 heading Digital & Commercial Innovation. Since February 2021 she serves, in addition to her previous role, as Chief Information Officer Pharmaceuticals. In this role she has been driving toward a more impactful and financially sustainable use of technologies supporting the entire Pharma value chain. In 2024, Jeanne became an independent advisor and  the CEO of LynxCare, before joining Sanofi as General Secretary since January 2025.